Randomized Phase II Multicenter Trial of Two Schedules of Lapatinib as First- or Second-Line Monotherapy in Patients with Advanced or Metastatic Non-Small Cell Lung Cancer

Helen J ROSS; George R BLUMENSCHEIN; Lance LEOPOLD; Tal Z ZAKS; Frances A SHEPHERD; Joseph AISNER; Nevena DAMJANOV; Afshin DOWLATI; Jennifer GARST; James R RIGAS; Michael SMYLIE; Habib HASSANI; Kimberly E ALLEN

doi:10.1158/1078-0432.CCR-08-3328

Back

Randomized Phase II Multicenter Trial of Two Schedules of Lapatinib as First- or Second-Line Monotherapy in Patients with Advanced or Metastatic Non-Small Cell Lung Cancer

Journal article

Open access

Peer reviewed

Randomized Phase II Multicenter Trial of Two Schedules of Lapatinib as First- or Second-Line Monotherapy in Patients with Advanced or Metastatic Non-Small Cell Lung Cancer

Helen J ROSS, George R BLUMENSCHEIN, Lance LEOPOLD, Tal Z ZAKS, Frances A SHEPHERD, Joseph AISNER, Nevena DAMJANOV, Afshin DOWLATI, Jennifer GARST, James R RIGAS, …

Clinical cancer research, Vol.16(6), pp.1938-1949

2010

DOI: https://doi.org/10.1158/1078-0432.CCR-08-3328

PMID: 20215545

Abstract

Tumors of the respiratory system and mediastinum

Biological and medical sciences

Medical sciences

Antineoplastic agents

Pharmacology. Drug treatments

Pneumology

Files and links (1)

url

https://doi.org/10.1158/1078-0432.CCR-08-3328View

Version of Record (VoR) Open

Metrics

14 Record Views

91 Times Cited - Web of Science

Details

Title: Randomized Phase II Multicenter Trial of Two Schedules of Lapatinib as First- or Second-Line Monotherapy in Patients with Advanced or Metastatic Non-Small Cell Lung Cancer
Creators: Helen J ROSS - Mayo Clinic, Scottsdale, Arizona, United States
George R BLUMENSCHEIN - University of Texas M.D. Anderson Cancer Center, Houston, Texas, United States
Lance LEOPOLD - GlaxoSmithKline, Collegeville, Pennsylvania, United States
Tal Z ZAKS - GlaxoSmithKline, Collegeville, Pennsylvania, United States
Frances A SHEPHERD - Princess Margaret Hospital, Toronto, Ontario, Canada
Joseph AISNER - Cancer Institute of New Jersey, New Brunswick, New Jersey, United States
Nevena DAMJANOV - University of Pennsylvania, Penn Presbyterian Medical Center, Philadelphia, Pennsylvania, United States
Afshin DOWLATI - University Hospitals of Cleveland, Cleveland, Ohio, United States
Jennifer GARST - Duke University Medical Center, Durham, North Carolina, United States
James R RIGAS - Dartmouth Hitchcock Medical Center, Lebanon, New Hampshire, United States
Michael SMYLIE - Cross Cancer Institute, Edmonton, Alberta, Canada
Habib HASSANI - GlaxoSmithKline, Collegeville, Pennsylvania, United States
Kimberly E ALLEN - GlaxoSmithKline, Collegeville, Pennsylvania, United States
Publication Details: Clinical cancer research, Vol.16(6), pp.1938-1949
Date published: 2010
Publisher: American Association for Cancer Research
Academic Unit: Lung Cancer/Thoracic Oncology Program
Language: English
Resource Type: Journal article
Identifiers: 991031654653404646